Modern’a melanoma vaccine goes after up to 34 artificially selected antigen targets, and it adds an otherwise unnecessary step. DCVax-l can elicit a broad spectrum (as many as 1200 different t-cell clones) of different t-cells to go after hundreds of antigen targets.